University of Minnesota. Driven to Discover.
Structure details may yield clues on how Zika damages cells and offer an inside track to drug, vaccine, and test developers.
Also, phase 2 trials just launched for two prime-boost Ebola vaccine regimens.
August 18, 2009
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.